Inventor · disambiguated record
Nikos Panayotatos
Also filed as: PANAYOTATOS NIKOS
17 granted patents·5 pending applications·247 citations·filing 1986–2006
95Inventor score
Top patents by PatentIndex Score
22 records- 0188US5846935AModified ciliary neurotrophic factorsREGENERON PHARMA·Filed 1994·Granted Dec 8, 1998·45 cites·14 claims
- 0282US5389529AModified lamβ signal sequence and processes for producing recombinant neurotrophinsREGENERON PHARMA·Filed 1991·Granted Feb 14, 1995·52 cites·6 claims
- 0381US5349056AModified ciliary neurotrophic factorsREGENERON PHARMA·Filed 1992·Granted Sep 20, 1994·27 cites·3 claims
- 0464US5256568AVectors and transformed most cells for recombinant protein production with reduced expression of selectable markersREGENERON PHAMACEUTICALS INC·Filed 1990·Granted Oct 26, 1993·21 cites·54 claims
- 0564US4716112AVectors for increased expression of cloned genesBIOGEN NV·Filed 1986·Granted Dec 29, 1987·20 cites·8 claims
- 0660US5914261AFamily of MAP2 protein kinasesREGENERON PHARMA·Filed 1995·Granted Jun 22, 1999·14 cites·11 claims
- 0759US6406710B1Protein occlusion for delivery of small moleculesFiled 1997·Granted Jun 18, 2002·17 cites·20 claims
- 0857US5872006AFamily of MAP2 protein kinasesREGENERON PHARMA·Filed 1995·Granted Feb 16, 1999·12 cites·18 claims
- 0955US2006269478A1Use of protein occlusion for the selective delivery of small molecules to targetsPANAYOTATOS NIKOS·Filed 2006·Application pending·0 cites
- 1055US2003220484A1Modified ciliary neurotrophic factorsFiled 2003·Application pending·0 cites
- 1154US2003092129A1Modified ciliary neurotrophic factorsFiled 2002·Application pending·0 cites
- 1253US2002004061A1Use of protein occlusion for the selective delivery of small molecules to targetsFiled 2001·Application pending·0 cites
- 1350US5595904AFamily of map2 protein kinasesREGENTS UNIV OF TEXAS BOARD OF·Filed 1994·Granted Jan 21, 1997·9 cites·20 claims
- 1447US6277963B1Antibodies directed toward extracellular signal-related kinasesREGENERON PHARMA·Filed 1997·Granted Aug 21, 2001·3 cites·12 claims
- 1547US5716803ARecombinant protein production with reduced expression of selectable markersREGENERON PHARMA·Filed 1993·Granted Feb 10, 1998·7 cites·19 claims
- 1647US2008031873A1Humanized monoclonal antibody 31.1 as an anticancer agentFASICK JEFFRY·Filed 2006·Application pending·0 cites
- 1746US5776751AFamily of MAP2 protein kinasesREGENERON PHARMA·Filed 1995·Granted Jul 7, 1998·6 cites·4 claims
- 1843US6410510B1Administration modified ciliary neurotrophic factorsREGENERON PHARMA·Filed 1996·Granted Jun 25, 2002·7 cites·2 claims
- 1942US6440702B1Nucleic acids encoding modified ciliary neurotrophic factorsREGENERON PHARMA·Filed 1998·Granted Aug 27, 2002·2 cites·6 claims
- 2035US6303358B1ERK3 MAP2 protein kinaseREGENERON PHARMA·Filed 1997·Granted Oct 16, 2001·2 cites·4 claims
- 2135US6297035B1ERK1 MAP2 protein kinaseREGENERON PHARMA·Filed 1997·Granted Oct 2, 2001·2 cites·4 claims
- 2224US6602687B1DNA encoding human ciliary neurotrophic factor and method for producing the protein encoded therebyREGENERON PHARMA·Filed 1992·Granted Aug 5, 2003·1 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Nikos Panayotatos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →